References
- Rapaport E. Mechanisms of anticancer activities of adenine nucleotides in tumor-bearing hosts. Ann NY Acad Sci 1990; 603: 142–50
- Rapaport E, Fishman R F, Gercel C. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res 1983; 43: 4402–6
- Weisman G A, Lustig K D, Lane E, Huang N, Belzer I, Friedberg I. Growth inhibition of transformed mouse fibro-blasts by adenine nucleotides occurs via generation of extracellular adenosine. J Biol Chem 1988; 263: 12367–72
- Gaba S JM, Prefaut C. Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease—ATP: A pulmonary controlled vasoregulator?. Eur Respir J 1986; 233: 309–19
- Burnstock G, Kennedy C. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone. Circ Res 1986; 58: 319–30
- Gordon J L. Extracellular ATP: Effects, sources and fate. Biochem J 1986; 233: 309–19
- Sung S J, Young J D, Origlio A M, Heiple J M, Kaback H R, Silverstein S C. Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. J Biol Chem 1985; 260: 13442–9
- Cowen D S, Lazarus H M, Shurin S B, Stoll S E, Dubyak G R. Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J Clin Invest 1988; 83: 1651–60
- Redegeld F, Filippini A, Sitkovsky M. Comparative studies of the cytotoxic T lymphocyte-mediated cytotoxicity and of extracellular ATP-induced cell lysis. J Immunol 1991; 147: 3638–45
- Gomaa A A. Characteristics of analgesia induced by adenosine triphosphate. Pharmacol Toxicol 1987; 61: 199–202
- Inoue K, Nakazawa K, Fujimori K, Takanaka A. Extracellular adenosine 5′-triphosphate-evoked norepinephrine secretion not relating to voltage-gated Ca channels in pheochromocytoma PC12 cells. Neuroscience Letters 1989; 106: 294–9
- Okunieff P, Froio J, Soni R, et al. Tumor growth retardation and pathophysiological effects of adenosine 5′-triphosphate therapy measured by thallium washout, 31P NMR, laser Doppler flowmetry, and intradermal angiogenesis. Radiat Oncol Invest 1994; 1: 346–60
- Okunieff P, Kallinowski F, Vaupel P, Neuringer L J. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. JNCI 1988; 80: 745–50
- Nolde S, Hilz H. The cytostatic action of extracellular NAD in tumor-bearing mice. Br J Cancer 1972; 26: 299–303
- Gericke D, Chandra P. Inhibition of tumor growth by nucleotide cyclic 3′,5′-monophosphates. Hoppe-Seyler's Z Physiol Chem 1969; 350: 1469–71
- Ryan W L, Heidrick M L. Inhibition of cell growth in vitro by adenosine 3′,5′-monophosphate. Science 1968; 162: 1484
- Fang W, Pirnia F, Bang Y, Myers C E, Trepel J B. P2-Purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 1992; 89: 191–6
- Rapaport E, Fontaine J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci USA 1989; 86: 1662–6
- Senagore A J, Milsom J W, Walshaw R K, Mostoskey U, Dunstan R, Chaudry I H. Adenosine triphosphate-magnesium chloride in radiation injury. Surgery 1992; 112: 933–9
- Urano M, Kim M S, Kahn J, Kenton L A, Li M L. Effect of thermochemotherapy (Combined cyclophosphamide and hyperthermia) given at various temperatures with or without glucose administration on a murine fibrosarcoma. Cancer Res 1985; 45: 4162–6
- Urano M, Kim M S. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma. Cancer Res 1983; 43: 3041–4
- Urano M, Majima H, Miller R, Kahn J. Cytotoxic effects of 1,3 bis (2-chloroethyl)-N-nitrosourea at elevated temperatures: Arrhenius plot analysis of tumour response. Int J Hyperthermia 1991; 7: 499–510
- Okunieff P G, Suit H D. Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas. J Natl Cancer Inst 1987; 79: 377–81
- Urano M, Kahn J, Kenton L A. The effect of cis-diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 1990; 6: 536–70